Chengming Liu

发表

Tumor microenvironment characterization identifies two lung adenocarcinoma subtypes with specific immune and metabolic state

Jiagen Li, N. Sun, Jie He, 2020, Cancer science.

Systematic analysis of IL-6 as a predictive biomarker and desensitizer of immunotherapy responses in patients with non-small cell lung cancer

N. Sun, Jie He, Yan Wang, 2022, BMC Medicine.

Image Interpolation via Scanning Line Algorithm and Discontinuous B-Spline

Chengming Liu, Chengming Liu, Haibo Pang, 2017 .

Desmoglein-2 Modulates Tumor Progression and Osimertinib Drug Resistance through the EGFR/Src/PAK1 Pathway in Lung Adenocarcinoma.

N. Sun, Jie He, Runsen Jin, 2020, Cancer letters.

S100A7 as a potential diagnostic and prognostic biomarker of esophageal squamous cell carcinoma promotes M2 macrophage infiltration and angiogenesis

N. Sun, Jie He, Zhiliang Lu, 2021, Clinical and translational medicine.

Systematic analysis of IL-6 as a predictive biomarker and desensitizer of immunotherapy responses in patients with non-small cell lung cancer

N. Sun, Jie He, Yan Wang, 2022, BMC Medicine.

Multichannel sparse deconvolution of seismic data with shearlet-Cauchy constrained inversion

Yonggang Wang, Deli Wang, Chengming Liu, 2017 .

Interferon-inducible lncRNA IRF1-AS represses esophageal squamous cell carcinoma by promoting interferon response.

Jiagen Li, N. Sun, Ning Li, 2019, Cancer letters.

The superior efficacy of anti-PD-1/PD-L1 immunotherapy in KRAS-mutant non-small cell lung cancer that correlates with an inflammatory phenotype and increased immunogenicity.

N. Sun, Jie He, Zhiliang Lu, 2020, Cancer letters.

Development and external validation of a composite immune-clinical prognostic model associated with EGFR mutation in East-Asian patients with lung adenocarcinoma

N. Sun, Jie He, Sufei Zheng, 2021, Therapeutic advances in medical oncology.

A novel recurrence-associated metabolic prognostic model for risk stratification and therapeutic response prediction in patients with stage I lung adenocarcinoma

N. Sun, Jie He, Yuanyuan Lei, 2021, Cancer biology & medicine.

TGF-β-induced PLEK2 promotes metastasis and chemoresistance in oesophageal squamous cell carcinoma by regulating LCN2

N. Sun, Jie He, Zhiliang Lu, 2021, Cell Death & Disease.

The Lifted Veil of Uncommon EGFR Mutation p.L747P in Non-Small Cell Lung Cancer: Molecular Feature and Targeting Sensitivity to Tyrosine Kinase Inhibitors

N. Sun, Jie He, Yan Wang, 2022, Frontiers in Oncology.

KRAS‐G12D mutation drives immune suppression and the primary resistance of anti‐PD‐1/PD‐L1 immunotherapy in non‐small cell lung cancer

N. Sun, Q. Xue, Yan Wang, 2022, Cancer communications.

Molecular heterogeneity of anti-PD-1/PD-L1 immunotherapy efficacy is correlated with tumor immune microenvironment in East Asian patients with non-small cell lung cancer

N. Sun, Jie He, Runsen Jin, 2020, Cancer biology & medicine.

Avoiding Absolute Quantification Trap: A Novel Predictive Signature of Clinical Benefit to Anti-PD-1 Immunotherapy in Non-Small Cell Lung Cancer

N. Sun, Q. Xue, Jie He, 2021, Frontiers in Immunology.

Aneuploid circulating tumor endothelial cells (CTECs) affect the detection of CTC, but they are fundamentally different

N. Sun, Jie He, Y. Che, 2020 .

The membrane-bound and soluble form of melanotransferrin function independently in the diagnosis and targeted therapy of lung cancer

N. Sun, Jie He, Y. Che, 2020, Cell death & disease.

Translational value of IDH1 and DNA methylation biomarkers in diagnosing lung cancers: a novel diagnostic panel of stage and histology-specificity

N. Sun, F. Zhou, Jie He, 2019, Journal of Translational Medicine.

Exosomal miR-141 promotes tumor angiogenesis via KLF12 in small cell lung cancer

N. Sun, Jie He, Zhiliang Lu, 2020, Journal of experimental & clinical cancer research : CR.

Exosomal miR-375-3p breaks vascular barrier and promotes small cell lung cancer metastasis by targeting claudin-1

N. Sun, Jie He, Zhiliang Lu, 2021, Translational lung cancer research.

Enhancement of diagnostic performance in lung cancers by combining CEA and CA125 with autoantibodies detection

N. Sun, F. Zhou, Jie He, 2019, Oncoimmunology.

The average copy number variation (CNVA) of chromosome fragments is a potential surrogate marker for TMB in predicting responses to immunotherapy in Non-small cell lung cancer

N. Sun, Jie He, Y. Che, 2020 .

ERO1L promotes IL6/sIL6R signaling and regulates MUC16 expression to promote CA125 secretion and the metastasis of lung cancer cells

N. Sun, Jie He, Y. Che, 2020, Cell Death & Disease.

PHD finger protein 5A promoted lung adenocarcinoma progression via alternative splicing

N. Sun, Jie He, Y. Che, 2019, Cancer medicine.

RANKL acts an unfavorable prognostic biomarker and potential target in advanced KRAS‐mutated lung adenocarcinoma

Yan Wang, Chengming Liu, Hong-Shuai Li, 2023, Thoracic cancer.

Survival-associated alternative splicing signatures in esophageal carcinoma

Jiagen Li, N. Sun, Ning Li, 2018, Carcinogenesis.

Combined detection of aneuploid circulating tumor‐derived endothelial cells and circulating tumor cells may improve diagnosis of early stage non‐small‐cell lung cancer

N. Sun, Jie He, Y. Che, 2020, Clinical and translational medicine.

Limited role of KRAS mutation in guiding immunotherapy in advanced non-small-cell lung cancer.

Yan Wang, Chengming Liu, Chengcheng Liu, 2022, Future oncology.

Making the Best Use of Available Weapons for the Inevitable Rivalry-Resistance to EGFR-TKIs

N. Sun, Yan Wang, Jie He, 2023, Biomedicines.

Translational value of IDH1 and DNA methylation biomarkers in diagnosing lung cancers: a novel diagnostic panel of stage and histology-specificity

N. Sun, F. Zhou, Jie He, 2019, Journal of Translational Medicine.

Systematic profiling of immune signatures identifies prognostic predictors in lung adenocarcinoma

Jiagen Li, N. Sun, Ning Li, 2020, Cellular Oncology.

The average copy number variation (CNVA) of chromosome fragments is a potential surrogate for tumor mutational burden in predicting responses to immunotherapy in non‐small‐cell lung cancer

N. Sun, Jie He, Y. Che, 2021, Clinical & translational immunology.

The Superior Efficacy of Anti-PD-1/PD-L1 Immunotherapy in KRAS-Mutant Non-Small Cell Lung Cancer that Correlates with an Inflammatory Phenotype and Increased Immunogenicity

N. Sun, Jie He, Zhiliang Lu, 2019, SSRN Electronic Journal.

The TGFβ-Induced Long Non-coding RNA TBULC Promotes the Invasion and Migration of Non-small Cell Lung Cancer Cells and Indicates Poor Prognosis

N. Sun, Jie He, Zhiliang Lu, 2019, Front. Oncol..

Analysis of functional hub genes identifies CDC45 as an oncogene in non-small cell lung cancer - a short report

N. Sun, Ning Li, Jie He, 2019, Cellular Oncology.

Analysis of functional hub genes identifies CDC45 as an oncogene in non-small cell lung cancer - a short report

N. Sun, Ning Li, Y. Che, 2019, Cellular Oncology.

A comprehensive pan-cancer analysis of prognostic value and potential clinical implications of FTH1 in cancer immunotherapy

N. Sun, Zhiliang Lu, Chengming Liu, 2024, Cancer immunology, immunotherapy : CII.

Genomic characteristics and immune landscape of super multiple primary lung cancer

He Tian, Shugeng Gao, Jiachen Xu, 2024, EBioMedicine.

Molecular subtypes of neuroendocrine carcinomas: A cross-tissue classification framework based on five transcriptional regulators.

N. Sun, Sufei Zheng, Chengming Liu, 2024, Cancer cell.